Abstract
Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Original language | Undefined/Unknown |
---|---|
Journal | Science Translational Medicine |
Volume | 6 |
Issue number | 235 |
DOIs | |
Publication status | Published - 2014 |
Research programs
- EMC MM-04-27-01